2026 NPPES data Hematology & Oncology Physician NPI 1235116591 MD
Verify on CMS →

AMARYLLIS GIL, MD

Hematology & Oncology Physician in ELMHURST, Illinois. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
837
Medicare Part D claims · 248 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
86%
generic claims · 14% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
91.3557/100
▲ 8 pts above national avg 83.1 · [object Object]
Industry payments
$2.2K
21 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

AMARYLLIS GIL, MD reported a CMS MIPS final score of 91.3557/100 — above the 83.1 national average — and filed 837 Medicare Part D claims in 2023.

91.3557/100
MIPS score · +8 vs avg
837
Part D claims, 2023
86%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

AMARYLLIS GIL, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

91 Top 37% higher than 63% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

AMARYLLIS GIL, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about AMARYLLIS GIL, MD?

High performer (top quartile)

NPI registry status

Active

Issued 12/28/2005

NPI 1235116591

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

837 1% vs specialty avg

2023 prescription claims

Specialty avg: 847

MIPS final score

91.3557/100 8.255700000000004% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Illinois

How Hematology & Oncology Physician compares to other specialties among Illinois providers

Illinois providers

Hematology & Oncology Physician share within Illinois

1. Hematology & Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hematology & Oncology Physician share within Illinois

Medicare quality performance — MIPS

AMARYLLIS GIL, MD's 2023 MIPS final score plotted against the Hematology & Oncology Physician national average

High performer (top quartile)
MIPS Final Score
91.3557/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Hematology & Oncology Physician) — 91.3557/100 vs national avg 83.1

0%100%National avg83%91.4%
MIPS final score (Hematology & Oncology Physician) — 91.3557/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

AMARYLLIS GIL, MD appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding MD credentials at 177 E BRUSH HILL RD, ELMHURST, IL, 60126, with a listed phone of (630) 646-2273. NPI 1235116591 was issued on 12/28/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what GIL most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 837 prescription claims written by this provider, covering 248 Medicare beneficiaries and totaling roughly $713K in drug spend, split 14% brand-name and 86% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 91.3557/100 for the 2023 performance year (Quality 82.7114), compared with the national average of 83.1.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

177 E BRUSH HILL RD
ELMHURST, IL 60126

Provider Details

NPI 1235116591
Specialty Hematology & Oncology Physician
Credentials MD
Gender Female
NPI Issued 12/28/2005

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

91.3557
Final Score
Avg: 83.1
82.7114
Quality
100
Promoting Interoperability

Reporting: Alternative Payment Model

Hospital and facility affiliations

Facilities where AMARYLLIS GIL, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

ENDEAVOR HEALTH MEDICAL GROUP
ELMHURST, IL

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for AMARYLLIS GIL, MD. Source: openpaymentsdata.cms.gov.

Total received

$2.2K

Largest payer

AstraZeneca UK Limited

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Illinois IDFPR 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~42K Illinois medical licensees in 2023 — they are NOT specific to AMARYLLIS GIL, MD. To verify AMARYLLIS GIL, MD's current license status, search the IDFPR public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

106
Total board actions, Illinois 2023
Across 103 cases
2.52
Actions per 1,000 licensees
Illinois statewide rate
probation
Most common action type
38 cases

IDFPR publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Illinois disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

AMARYLLIS GIL, MD — brand share 14.0%
Specialty average (est.)

14% brand-name claims vs 86% generic, on 837 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

837
Total Claims
$713K
Total Drug Cost
248
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,789
Total Day Supply
52,442
Brand vs Generic
14% brand / 86% generic
Brand Drug Cost
$671K
Generic Drug Cost
$42K
Antibiotic Claims
19

Patient Demographics

Average Patient Age
74.2 years
Avg HCC Risk Score
1.83
Gender Split
85% female / 15% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What AMARYLLIS GIL, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Letrozole
218
Anastrozole
124
Gabapentin
48
Tamoxifen Citrate
37
Eliquis
Apixaban
31
Xarelto
Rivaroxaban
28
Hydroxyurea
24
Raloxifene Hcl
24
Acyclovir
23
Dexamethasone
20

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How AMARYLLIS GIL, MD fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

AMARYLLIS GIL, MD's 837 claims are below the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in Illinois

Other clinicians with the same primary specialty enrolled in Illinois, drawn from the same CMS NPPES roster as GIL.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is AMARYLLIS GIL, MD's specialty?
AMARYLLIS GIL, MD specializes in Hematology & Oncology Physician and practices in ELMHURST, Illinois. Credentials: MD.
How much does AMARYLLIS GIL, MD prescribe under Medicare Part D?
In 2023, AMARYLLIS GIL, MD wrote 837 Medicare Part D claims totaling $713K in drug costs for 248 beneficiaries.
What is AMARYLLIS GIL, MD's Medicare quality score?
AMARYLLIS GIL, MD has a CMS MIPS Final Score of 91.3557/100 (Quality: 82.7114). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is AMARYLLIS GIL, MD located?
AMARYLLIS GIL, MD is located at 177 E BRUSH HILL RD, ELMHURST, IL, 60126. Phone: (630) 646-2273.
What is AMARYLLIS GIL, MD's NPI number?
AMARYLLIS GIL, MD's National Provider Identifier (NPI) is 1235116591, issued on 12/28/2005.
Does AMARYLLIS GIL, MD prescribe more brand-name or generic drugs?
AMARYLLIS GIL, MD's prescribing is 14% brand-name and 86% generic drugs by claim count, with $671K in brand drug costs.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does AMARYLLIS GIL, MD prescribe most often?
Based on 2023 Medicare Part D data, AMARYLLIS GIL, MD's most frequently prescribed drugs include Letrozole, Anastrozole, Gabapentin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does AMARYLLIS GIL, MD accept Medicare?
AMARYLLIS GIL, MD appears in CMS Medicare data with 837 Part D claims and 248 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify AMARYLLIS GIL, MD's credentials?
AMARYLLIS GIL, MD's NPI is 1235116591 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology